PAN
Showing 1 - 25 of 3,549
Percutaneous Coronary Intervention, Pan-vascular Interventional Robotic System Trial in Kashgar (Pan-vascular interventional
Not yet recruiting
- Percutaneous Coronary Intervention
- Pan-vascular Interventional Robotic System
- Pan-vascular interventional robotic system
-
Kashgar, Xinjiang, ChinaKashi Prefecture Second People's Hospital
Oct 30, 2023
Pan Immune Inflammatory Index and Endometriosis
Active, not recruiting
- Relationship Between Pan Immune Inflammatory Index and Endometriosis and Endometriosis Stages
-
Ankara, Yenimahalle, TurkeyAnkara Etlik City Hospital
Nov 16, 2023
Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)
Recruiting
- Solid Tumor
- EGFR Amplification
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 28, 2023
Cancer, Cancer Gene Mutation, PAN Gene Mutation Trial in Scottsdale, Jacksonville, Rochester (Pan-genomic Testing)
Not yet recruiting
- Cancer
- +2 more
- Pan-genomic Testing
-
Scottsdale, Arizona
- +2 more
Aug 18, 2023
Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)
Recruiting
- Solid Tumor
- +4 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 28, 2023
Malaria Trial in Lambaréné (Vaccine AnAPN1)
Not yet recruiting
- Malaria
- Vaccine AnAPN1
-
Lambaréné, Moyen- Ogooué, GabonCentre de Recherches Médicales de Lammbaréné
Jun 21, 2023
PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only
Not yet recruiting
- PARP Inhibitor for Esophageal Squamous Cell Carcinoma
- Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
- (no location specified)
Sep 24, 2023
Iron Deficiency Anemia, GastroIntestinal Bleeding Trial in Guimarães (Pan-intestinal capsule endoscopy)
Recruiting
- Iron Deficiency Anemia
- GastroIntestinal Bleeding
- Pan-intestinal capsule endoscopy
-
Guimarães, PortugalGastroenterology Department, Hospital da Senhora da Oliveira
Aug 1, 2022
Advanced Solid Tumor Trial in Guangzhou (YL-17231)
Recruiting
- Advanced Solid Tumor
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 5, 2023
Lung Cancer Trial in Brampton (Questionnaires)
Recruiting
- Lung Cancer
- Questionnaires
-
Brampton, Ontario, CanadaMilena (Lynn) Vicente
Jun 17, 2022
Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)
Not yet recruiting
- Influenza, Human
- FLU Q-PAN H5N8 Formulation 1
- +3 more
- (no location specified)
Jul 27, 2023
Evaluation Of The Pan-microbiome and Host Immune Response in CF
Active, not recruiting
- Cystic Fibrosis (CF)
- Two-Bronchoscope Technique
-
New York, New YorkNew York University School of Medicine
Aug 3, 2022
Post-ERCP Acute Pancreatitis Trial in San Francisco, Philadelphia
Active, not recruiting
- Post-ERCP Acute Pancreatitis
-
San Francisco, California
- +1 more
Jul 22, 2022
Physician and Molecular Tumor Board Perspectives on Clinical
Recruiting
- Pan-cancer
- Cellworks Singula and Ventura reports
-
Sioux Falls, South DakotaAvera McKennan
Apr 1, 2022
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Recruiting
- Cancer
- DNA methylation test
-
Zhengzhou, Henan, ChinaThe first affiliated hospital of Zhengzhou University
Jan 5, 2023
Tumor, Solid Trial in Caen, Lille (RCMI in painting dose on histoscannographic mapping, Standard pan-sinusal IMRT)
Not yet recruiting
- Tumor, Solid
- RCMI in painting dose on histoscannographic mapping
- Standard pan-sinusal IMRT
-
Caen, France
- +2 more
Jul 5, 2023
Non-infectious Intermediate Posterior- or Pan-uveitis Trial in China (Adalimumab)
Recruiting
- Non-infectious Intermediate Posterior- or Pan-uveitis
-
Beijing, Beijing, China
- +7 more
Dec 6, 2022
Clinical Study of LBBP
Recruiting
- Bradyarrhythmias
- Heart Failure
- pacemaker implantation
-
Hangzhou, Zhejiang, ChinaXiaohong Pan
Jan 29, 2023
Diabetes, Type 2 Trial (Methodological intervention, Toujeo)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Methodological intervention
- Toujeo
- (no location specified)
Mar 21, 2023
Transthyroxine Amyloidosis Cardiomyopathy Trial in Hangzhou (ATTR-CM)
Recruiting
- Transthyroxine Amyloidosis Cardiomyopathy
-
Hangzhou, Zhejiang, Chinaxiaohong University PAN
Jan 29, 2023
Falls From Sitting to Standing
Completed
- Falls, Tomography of the Head, Cervical Spine, Chest, Abdomen, and Pelvis
- tomography pan scan
-
New York, New YorkSIUH Northwell Health
Jun 6, 2022
A Pan-European Post-Authorisation Safety Study: Risk of
Not yet recruiting
- Pancreatic Cancer
- Exenatide
- Non-GLP-1 RA based glucose lowering drugs
- (no location specified)
Dec 21, 2022